Loading…
Elicio Therapeutics, Inc.
Elicio Therapeutics, Inc. (ELTX) is listed on NASDAQ and classified in Biotechnology, part of the Healthcare sector. It is headquartered in Boston, United States and has 33 employees. The company is worth $42.26M. Revenue was $2.3M in fiscal 2022, down 91.9% from the year before. It reported a net loss of $28.21M. The share price is 90.3% below its 52-week high of $16.00. None of the 38 superinvestors we track reported it in their latest 13F. No open-market insider trades in it were filed over the last 30 days.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Major managers that reported this stock in their latest 13F.
None of the investors we track reported a position in ELTX.
▼ -95.7% over 5Y.
today you would have $37.41▼ -96.3%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 5 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Year-end price | $7.96 | $5.10 | $8.34 | $8.12 | $29.00 | |
| P/S | — | — | — | — | 10.6x | 3.1x |
| P/B | — | 91.0x | — | 7.5x | — | — |
| EPS | -$2.58 | -$4.25 | -$6.96 | -$89.27 | -$19.30 | |
| Profit margin |
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| ANVSAnnovis Bio, Inc. | $0.99 | — | — | 0.00% | -703.68% | $42.4M |
| SNWVSANUWAVE Health, Inc. | $4.96 | 20.7x | 15.3x | 0.00% | — | $42.67M |
| ACETAdicet Bio, Inc. | $4.57 | — | 0.4x | 0.00% | -78.08% | $42.78M |
| DWTXDogwood Therapeutics, Inc. | $1.22 |
| — |
| — |
| — |
| — |
| -1225.90% |
| -192.76% |
| ROE | — | -2418.77% | — | -309.46% | — | — |
Median of the years shown; P/E years above 200x are left out.
| 0.6x |
| 0.6x |
| 0.00% |
| -47.77% |
| $41.47M |
| INMBInmune Bio, Inc. | $1.57 | — | 2.1x | 0.00% | -74.82% | $43.57M |
| SERSerina Therapeutics, Inc. | $1.72 | — | 2.3x | 0.00% | -207.94% | $43.69M |